Physician Profile
Jiakai Zhu, MD practices urology in Annapolis, MD. Jiakai is a 2012 graduate of University of Maryland School of Medicine. Medicare claims data shows Jiakai provided 18,565 services to 5,426 patients. The services billed most often include leuprolide injectable, camcevi, 1 mg, bcg live intravesical instillation, 1 mg, and injection, denosumab, 1 mg. The provider's National Provider Identifier (NPI) is 1629271507.
Factual summary compiled by Guide.md from public records; not written by this provider.
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
600 RIDGELY AVE SUITE 130
Annapolis, MD 21401
Within Urology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Most searched conditions
Bladder and urethra
Kidney and ureter
Male reproductive and sexual health
Prostate
Urinary symptoms and infection
Bladder & Urination
Kidney health
Men's health
Urinary symptoms
Most searched procedures
Office diagnosis
Bladder procedures
Diagnostic imaging
Kidney & ureter procedures
Kidney and ureter surgery
Male reproductive
Prostate
Prostate procedures
Stone procedures
18,565 services · 5,426 patients · 25 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Ultrasound measurement of bladder capacity after voiding | Procedure | 51798 |
1,025 | More than most peers in Urology |
| Diagnostic exam of bladder and urethra using an endoscope | Procedure | 52000 |
103 | More often than most peers in Urology |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Treatment | 96402 |
234 | More than most peers in Urology |
| Leuprolide injectable, camcevi, 1 mg | Drug given | J1952 |
4,116 | More than most peers in Urology |
| Bcg live intravesical instillation, 1 mg | Drug given | J9030 |
2,300 | More often than most peers in Urology |
| Injection, denosumab, 1 mg | Drug given | J0897 |
2,100 | Less often than most peers in Urology |
| Leuprolide acetate (for depot suspension), 7.5 mg | Drug given | J9217 |
822 | More than most peers in Urology |
| Detection test by nucleic acid for organism, amplified probe technique | Lab test | 87798 |
1,421 | More often than most peers in Urology |
| Urinalysis, manual test | Lab test | 81002 |
1,312 | More than most peers in Urology |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient' | Billing code | G2211 |
1,291 | More than most peers in Urology |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Dr. Zhu is an urologist in Annapolis, MD. That is the designation recorded for this NPI in the federal registry, where it is listed as “Urology”.
NPI registry
Dr. Zhu is listed at 600 Ridgely Ave Suite 130, Annapolis, MD 21401. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (410) 266-8049. Contact the office directly to confirm availability and scheduling.
NPI registry
Dr. Zhu's National Provider Identifier is 1629271507. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Dr. Zhu attended University of Maryland School of Medicine, graduating in 2012. This comes from the CMS National Downloadable File.
CMS public data
Dr. Zhu has 14 years experience. Calculated from a graduation year of 2012, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, Dr. Zhu performs procedures including ultrasound measurement of bladder capacity after voiding and diagnostic exam of bladder and urethra using an endoscope; provides treatments such as administration of hormonal anti-neoplastic chemotherapy under skin or into muscle, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by Dr. Zhu. If this is you, claiming it is free.
Guide.md
Guide.md listings do not constitute medical advice or an endorsement.